valdecoxib nonsteroidal antiinflammatory drug nsaid used treatment osteoarthritis rheumatoid arthritis painful menstruation menstrual symptoms selective inhibitor patented valdecoxib manufactured marketed brand name bextra g searle company antiinflammatory arthritis approved united states food drug administration fda november treat arthritis menstrual available prescription tablet form fda requested pfizer withdraw bextra american fda cited potential increased risk serious cardiovascular cv adverse events increased risk serious skin reactions fact bextra shown offer unique advantages available bextra center largest healthcare fraud settlement largest criminal fine kind pfizer paid billion civil criminal fine pharmacia upjohn pfizer subsidiary violated united states food drug cosmetic act misbranding bextra intent defraud watersoluble injectable prodrug valdecoxib parecoxib marketed european union tradename dynastat united states fda approved valdecoxib treatment osteoarthritis adult rheumatoid arthritis primary valdecoxib also used offlabel controlling acute pain various types surgical april pfizer withdrew bextra us market recommendation fda citing increased risk heart attack stroke also risk serious sometimes fatal skin reaction result recent attention prescription nsaids mercks vioxx reported side effects angina syndrome pfizer first acknowledged cardiovascular risks associated bextra october american heart association soon presented report indicating patients using bextra recovering heart surgery times likely suffer stroke heart attack taking placebos large study published journal american medical association valdecoxib appeared less adverse renal kidney disease heart arrhythmia compared vioxx elevated renal risks slightly september united states department justice fined pfizer billion one subsidiaries pharmacia upjohn company pleaded guilty marketing four drugs including bextra intent defraud pharmacia upjohn admitted criminal conduct promotion bextra agreed pay largest criminal fine ever imposed united states matter former pfizer district sales manager indicted sentenced home confinement destroying documents regarding illegal promotion addition regional manager pleaded guilty distribution misbranded product fined months remaining billion fine paid resolve allegations civil false claims act case largest civil fraud settlement pharmaceutical company six whistleblowers awarded million role former pfizer sales representative john kopchinski acted qui tam relator filed complaint outlining illegal conduct marketing kopchinski awarded million role case improper marketing bextra largest piece settlement several hplcuv reported valdecoxib estimation biological samples like human valdecoxib analytical methods bioequivalence metabolite estimation hptlc method simultaneous estimation tablet dosage httpsenwikipediaorgwikivaldecoxib